Clinical Trial Update: Bioequivalence of LB80380 Free Base and Maleate Salt Tablets [Phase 1]

View source ↗

Summary

Phase 1 trial assessing bioequivalence between LB80380 free base and LB80380 maleate salt tablets in Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• LB80380

Snippet

Sponsor: LG Life Sciences | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED